PaulineFunchainMD

Cancer Genetics/Cancer Risk Assessment, Melanoma

Medical Oncology/Cancer Genetics

Dr. Funchain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2009 - 2012
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006

PubMed

Long-term cardiovascular outcomes of immune checkpoint inhibitor-related myocarditis: A large single-centre analysis.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer
ESC Heart Failure. 2025-04-01
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.
Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, Ryan Denu, Walid Macaron
Journal for Immunotherapy of Cancer. 2025-03-03
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants.
Isabella Ribaudo, Michelle Arbesman, Ying Ni, James Isaacs, Lucy Boyce Kennedy
Pigment Cell & Melanoma Research. 2025-03-01

Abstracts/Posters

Biomarker Assessment of Venous Thromboembolism in Cancer Patients Receiving Checkpoint Blockade
Pauline Funchain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Multiplex germline testing in selected melanomas presenting to oncology clinic.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

‘Cure’ in Cancer: Should Oncologists Use the Word?February 4th, 2025
Inherited Risk May Play a Larger Role in Melanoma Than Previously BelievedJune 20th, 2024
Inherited Genes Play a Larger Role in Melanoma Risk Than Previously BelievedMay 23rd, 2024
Join now to see all